Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
Conditions
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
Interventions
- DRUG: Venetoclax
- DRUG: Amsacrine
- DRUG: Ara-C
- DRUG: Tacrolimus
- DRUG: Mycophenolate Mofetil
Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators